open access

Vol 75, No 9 (2017)
Original articles
Published online: 2017-05-18
Submitted: 2016-11-22
Accepted: 2017-03-20
Get Citation

How does ivabradine effect erectile dysfunction in patients with heart failure?

Fatih Aydın, Serkan Bektur, Yasin Taşdelen, Yüksel Kıvrak, Ayşe Hüseyinoglu Aydın
DOI: 10.5603/KP.a2017.0095
·
Kardiol Pol 2017;75(9):893-898.

open access

Vol 75, No 9 (2017)
Original articles
Published online: 2017-05-18
Submitted: 2016-11-22
Accepted: 2017-03-20

Abstract

Background: Erectile dysfunction (ED) is the inability or insufficiency of penile erection that causes dissatisfaction during sexual intercourse. ED is seen in patients with heart failure (HF), ranging from 56% to 81% depending on the severity. Patients usually blame their cardiovascular medications for their ED. Ivabradine is used for antianginal effects, to improve exercise intolerance, and to decrease mortality in patients with HF. Most beta-blockers are known to cause ED, but unlike beta-blockers the effect of ivabradine over ED has never been evaluated.

Aim: We investigated the effect of ivabradine on ED in patients with HF.

Methods: Thirty-one patients with HF (all men) under optimal treatment for HF (except ivabradine) were recruited. Patients were evaluated with the internationally validated Sexual Health Inventory for Men (SHIM) questionnaire before the initiation of ivabradine and at the sixth month of the treatment. SHIM scores previous to treatment and at six months were compared using Wilcoxon signed rank test. A p value < 0.05 was accepted as statistically significant.

Results: At six months of follow-up after the initiation of ivabradine, a significant increase in patients with normal libido was found (p < 0.001).

Conclusions: This is a novel study that evaluates the effect of ivabradine on human with HF. Ivabradine improved libido in patients with HF.

Abstract

Background: Erectile dysfunction (ED) is the inability or insufficiency of penile erection that causes dissatisfaction during sexual intercourse. ED is seen in patients with heart failure (HF), ranging from 56% to 81% depending on the severity. Patients usually blame their cardiovascular medications for their ED. Ivabradine is used for antianginal effects, to improve exercise intolerance, and to decrease mortality in patients with HF. Most beta-blockers are known to cause ED, but unlike beta-blockers the effect of ivabradine over ED has never been evaluated.

Aim: We investigated the effect of ivabradine on ED in patients with HF.

Methods: Thirty-one patients with HF (all men) under optimal treatment for HF (except ivabradine) were recruited. Patients were evaluated with the internationally validated Sexual Health Inventory for Men (SHIM) questionnaire before the initiation of ivabradine and at the sixth month of the treatment. SHIM scores previous to treatment and at six months were compared using Wilcoxon signed rank test. A p value < 0.05 was accepted as statistically significant.

Results: At six months of follow-up after the initiation of ivabradine, a significant increase in patients with normal libido was found (p < 0.001).

Conclusions: This is a novel study that evaluates the effect of ivabradine on human with HF. Ivabradine improved libido in patients with HF.

Get Citation

Keywords

heart failure, ivabradine, erectile dysfunction

About this article
Title

How does ivabradine effect erectile dysfunction in patients with heart failure?

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Vol 75, No 9 (2017)

Pages

893-898

Published online

2017-05-18

DOI

10.5603/KP.a2017.0095

Bibliographic record

Kardiol Pol 2017;75(9):893-898.

Keywords

heart failure
ivabradine
erectile dysfunction

Authors

Fatih Aydın
Serkan Bektur
Yasin Taşdelen
Yüksel Kıvrak
Ayşe Hüseyinoglu Aydın

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., Świętokrzyska 73 street, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl